Androgen receptor molecular biology and potential targets in prostate cancer
The androgen receptor (AR) is a key transcriptional regulator and therapeutic target in prostate cancer. During androgen deprivation therapy to treat metastatic prostate cancer, surviving cells acquire increased AR signaling through a variety of mechanisms, one of which is enhanced interactions with...
Main Author: | Elizabeth M. Wilson |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2010-06-01
|
Series: | Therapeutic Advances in Urology |
Online Access: | https://doi.org/10.1177/1756287210372380 |
Similar Items
-
Androgen Receptor-Directed Molecular Conjugates for Targeting Prostate Cancer
by: Giovanni L. Beretta, et al.
Published: (2019-05-01) -
Androgen receptor and prostate cancer
by: Karen E. Livermore, et al.
Published: (2016-06-01) -
Role of Androgen Receptor-Targeted Agents in Localized Prostate Cancer
by: Jure Murgić, et al.
Published: (2022-01-01) -
The evolution of prostate cancer therapy: targeting the androgen receptor (AR)
by: Jeanny B. Aragon-Ching
Published: (2014-10-01) -
Androgen receptor cofactors: A potential role in understanding prostate cancer
by: Xiang Li, et al.
Published: (2024-04-01)